Salarius Pharmaceuticals Clarifies Nasdaq Listing Status

Salarius Pharmaceuticals reports that certain financial market data platforms have inaccurately stated that the company has been delisted from Nasdaq. The company's common stock is still listed and traded on the Nasdaq Capital Market under the ticker symbol "SLRX." Salarius had previously regained compliance with Nasdaq's minimum bid price and equity standards, and had completed a strategic merger transaction. The company has contacted the platforms to correct the inaccurate information.